Condensed Statements of Operations and Comprehensive Loss (unaudited) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Operating expenses:
Research and development	$ 21,450	$ 10,488	$ 55,065	$ 31,554
General and administrative	6,674	3,094	16,812	9,632
Total operating expenses	28,124	13,582	71,877	41,186
Loss from operations	(28,124)	(13,582)	(71,877)	(41,186)
Interest income, net	3,655	662	10,693	1,838
Other expense	(71)	(14)	(127)	(41)
Net loss	$ (24,540)	$ (12,934)	$ (61,311)	$ (39,389)
Net loss per share, basic	$ (0.63)	$ (0.55)	$ (1.63)	$ (1.77)
Net loss per share, diluted	$ (0.63)	$ (0.55)	$ (1.63)	$ (1.77)
Weighted-average shares outstanding, basic	38,957,524	23,487,457	37,724,402	22,299,998
Weighted-average shares outstanding, diluted	38,957,524	23,487,457	37,724,402	22,299,998
Comprehensive loss:
Net Income (Loss)	$ (24,540)	$ (12,934)	$ (61,311)	$ (39,389)
Unrealized gain (loss) on short-term investments	1,175	109	778	511
Comprehensive loss	$ (23,365)	$ (12,825)	$ (60,533)	$ (38,878)